Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Bile Etiology,Proteomics and Metabonomics of Malignant Biliary Obstruction

NCT01073514 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.

NCT NCT01073514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01073514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Bile Etiology,Proteomics and Metabonomics of Malignant Biliary Obstruction
Lead sponsor
Tianjin Medical University Cancer Institute and Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2009
Completion date
December 31, 2016
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant biliary obstruction